George Poste

Chf Scientist & Regent's Prof

Director AZ BioDesign Institute, BI: Bioenergetics, Center for (BE)
Chief Scientist & Regents' Professor, BI: Personalized Diagnostics, Virginia G. Piper Center for (PD)
Chief Scientist & Regents'' Professor, Knowledge Enterprise Development, Office of (OKED)
Chief Scientist & Regents' Professor, BI: Innovations in Medicine, Center for (IM)
Chief Scientist & Regents' Professor, Complex Adaptive Systems (CAS)
Chief Scientist & Regents' Professor, CLAS-NS: Life Sciences, School of (SOLS)
Director AZ BioDesign Institute, BI: Immunotherapy, Vaccines and Virotherapy, Center for (CIVV)

13369 Citations
61 h-Index

If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Education/Academic qualification

DSc, University of Bristol

… → 1987

PHD, University of Bristol

… → 1969

DVM, University of Bristol

… → 1966

Fingerprint Dive into the research topics where George Poste is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Cell Fusion Medicine & Life Sciences

Liposomes Medicine & Life Sciences

Macrophages Medicine & Life Sciences

Neoplasm Metastasis Medicine & Life Sciences

Neoplasms Medicine & Life Sciences

Cultured Cells Medicine & Life Sciences

Viruses Medicine & Life Sciences

Viral Cytopathogenic Effect Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1970 2019

13369 Citations
61 h-Index
243 Article
9 Chapter
1 Comment/debate
1 Review article

Serving Individuals and Populations Within Integrated Health Systems: A Bridge Too Far?

Moses, H., Matheson, D. H. M. & Poste, G., Jan 1 2019, In : JAMA - Journal of the American Medical Association.

Research output: Contribution to journal › Comment/debate

Health

Population

22 Citations (Scopus)

Adaptive global innovative learning environment for glioblastoma: GBM AGILE

GBM AGILE Network, Feb 15 2018, In : Clinical Cancer Research. 24, 4, p. 737-743 7 p.

Research output: Contribution to journal › Review article

Glioblastoma

Learning

Biomarkers

Therapeutics

Random Allocation

8 Citations (Scopus)

Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes

Domenyuk, V., Gatalica, Z., Santhanam, R., Wei, X., Stark, A., Kennedy, P., Toussaint, B., Levenberg, S., Wang, J., Xiao, N., Greil, R., Rinnerthaler, G., Gampenrieder, S. P., Heimberger, A. B., Berry, D. A., Barker, A., Quackenbush, J., Marshall, J. L., Poste, G., Vacirca, J. L. & 9 others, Vidal, G. A., Schwartzberg, L. S., Halbert, D. D., Voss, A., Magee, D., Miglarese, M. R., Famulok, M., Mayer, G. & Spetzler, D., Dec 1 2018, In : Nature Communications. 9, 1, 1219.

Research output: Contribution to journal › Article

breast

cancer

Breast Neoplasms

Ligands

ligands

The challenge of liposome targeting in vivo

Poste, G., Kirsh, R. & Koestler, T., Jan 1 2018, Liposome Technology: Volume III: Targeted Drug Delivery and Biological Interaction. CRC Press, p. 1-28 28 p.

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Liposomes

1 Citation (Scopus)

The challenge of liposome targeting in vivo

Poste, G., Kirsh, R. & Koestler, T., Jan 1 2018, Liposome Technology Volume III: Targeted Drug Delivery and Biological Interaction. CRC Press, p. 1-28 28 p.

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Liposomes

Literature

Drug Carriers

Newspapers

Television